We are live on
!
Find out more
AAP
Arax Advisory Partners Portfolio holdings
AUM
$3.54B
1-Year Est. Return
19.14%
This Fund
S&P 500
This Quarter
Est. Return
+8.62%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
–
AUM
$6.97B
AUM Growth
+$4.79B
(+220%)
Cap. Flow
+$6.91B
Cap. Flow
% of AUM
99.25%
Top 10 Holdings %
Top 10 Hldgs %
36.51%
Holding
4,400
New
1,371
Increased
1,984
Reduced
143
Closed
794
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 100 ETF
OEF
|
+$2.43B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.24B |
| 3 |
DFAI
Dimensional International Core Equity Market ETF
DFAI
|
+$202M |
| 4 |
American Century Diversified Corporate Bond ETF
KORP
|
+$152M |
| 5 |
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Growth ETF
VUG
|
+$91.2M |
| 2 |
Vanguard Morningstar Value ETF
VTV
|
+$62.6M |
| 3 |
AXON
Axon Enterprise
AXON
|
+$58.1M |
| 4 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$46.5M |
| 5 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$44.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.48% |
| 2 | Financials | 8.05% |
| 3 | Industrials | 7.03% |
| 4 | Consumer Discretionary | 6.62% |
| 5 | Healthcare | 6.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STKL
3201
DELISTED
SunOpta
STKL
| $1.28K | ﹤0.01% |
+218
| New | +$1.35K |
|
3202
CVRx
CVRX
$146M
| $1.26K | ﹤0.01% |
+156
| New | +$1.17K |
|
3203
Prospect Capital
PSEC
$1.09B
| $1.25K | ﹤0.01% |
+453
| New | +$1.35K |
|
3204
AMC Entertainment Holdings
AMC
$2.38B
| $1.24K | ﹤0.01% |
+428
| New | +$1.27K |
|
3205
Nuveen Credit Strategies Income Fund
JQC
$708M
| $1.24K | ﹤0.01% |
235
| – | – |
|
3206
LSI Industries
LYTS
$918M
| $1.23K | ﹤0.01% |
+52
| New | +$1.06K |
|
|
FBLA
3207
FB Bancorp
FBLA
$254M
| $1.23K | ﹤0.01% |
+102
| New | +$1.21K |
|
3208
Greenwich LifeSciences
GLSI
$211M
| $1.22K | ﹤0.01% |
+123
| New | +$1.39K |
|
3209
Vera Therapeutics
VERA
$2.18B
| $1.22K | ﹤0.01% |
+42
| New | +$971 |
|
|
MRSN
3210
DELISTED
Mersana Therapeutics
MRSN
| $1.22K | ﹤0.01% |
+157
| New | +$1.18K |
|
|
MAGN
3211
Magnera Corp
MAGN
$482M
| $1.22K | ﹤0.01% |
104
+20
| +24% | +$248 |
|
3212
Rezolute
RZLT
$451M
| $1.21K | ﹤0.01% |
+129
| New | +$859 |
|
|
TBRG
3213
DELISTED
TruBridge
TBRG
| $1.21K | ﹤0.01% |
+60
| New | +$1.26K |
|
3214
Southern Missouri Bancorp
SMBC
$868M
| $1.21K | ﹤0.01% |
+23
| New | +$1.28K |
|
|
GEMI
3215
Gemini Space Station
GEMI
$510M
| $1.2K | ﹤0.01% |
+50
| New | +$1.29K |
|
3216
Waldencast
WALD
$190M
| $1.2K | ﹤0.01% |
+604
| New | +$1.21K |
|
3217
Tyra Biosciences
TYRA
$1.53B
| $1.19K | ﹤0.01% |
+85
| New | +$969 |
|
|
SEPN
3218
Septerna Inc
SEPN
$1.75B
| $1.19K | ﹤0.01% |
+63
| New | +$827 |
|
3219
VTEX
VTEX
$755M
| $1.18K | ﹤0.01% |
+269
| New | +$1.36K |
|
3220
Caribou Biosciences
CRBU
$160M
| $1.18K | ﹤0.01% |
+506
| New | +$955 |
|
3221
Lifezone Metals
LZM
$355M
| $1.17K | ﹤0.01% |
+214
| New | +$984 |
|
3222
Mobileye
MBLY
$2.13B
| $1.17K | ﹤0.01% |
+83
| New | +$1.23K |
|
3223
ASP Isotopes
ASPI
$510M
| $1.16K | ﹤0.01% |
+120
| New | +$1.11K |
|
3224
Lakeland Industries
LAKE
$123M
| $1.16K | ﹤0.01% |
+78
| New | +$1.14K |
|
|
DOYU
3225
DouYu International Holdings
DOYU
$144M
| $1.15K | ﹤0.01% |
+153
| New | +$1.2K |
|
Similar funds
TYCC
TH
BCP
WWA
VPC
BPS
TCM
DILIC
Arax Advisory Partners's Q3 2025 Portfolio in Review
As of Q3 2025, Arax Advisory Partners held 4,400 positions worth $6.97B, up 220% from $2.18B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Arax Advisory Partners deployed $6.91B of net new capital in Q3 2025, opening 1,371 new positions and adding to 1,984 existing holdings. Its largest new stake was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 6.5% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Axon Enterprise, an estimated $58.1M trimmed.
- Arax Advisory Partners's largest Q3 2025 buy was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.
- Arax Advisory Partners added most to iShares S&P 100 ETF in Q3 2025, an estimated $2.43B increase.
- Arax Advisory Partners's biggest Q3 2025 reduction was Axon Enterprise, cutting an estimated $58.1M.
- Arax Advisory Partners fully exited Vanguard Morningstar Growth ETF in Q3 2025, selling an estimated $91.2M.
- Arax Advisory Partners's ten largest holdings make up 37% of its $6.97B portfolio in Q3 2025.
- Arax Advisory Partners opened 1,371 new positions and closed 794 in Q3 2025.
- Arax Advisory Partners's portfolio value rose 220% quarter-over-quarter to $6.97B.
Based on Arax Advisory Partners's 13F filing for Q3 2025, filed 14 Nov 2025.